Tinavi Medical Technologies Co Ltd Asset Resilience Ratio
Tinavi Medical Technologies Co Ltd asset resilience ratio. Tinavi Medical Technologies Co Ltd (688277) has an Asset Resilience Ratio of 2.05% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688277 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Tinavi Medical Technologies Co Ltd (2015–2025)
Asset resilience ratio of Tinavi Medical Technologies Co Ltd from 2015 to 2025. This chart shows how Tinavi Medical Technologies Co Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Tinavi Medical Technologies Co Ltd carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Tinavi Medical Technologies Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 688277 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥33.62 Million | 2.05% |
| Total Liquid Assets | CN¥33.62 Million | 2.05% |
Asset Resilience Insights
- Limited Liquidity: Tinavi Medical Technologies Co Ltd maintains only 2.05% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tinavi Medical Technologies Co Ltd Industry Peers by Asset Resilience Ratio
Compare Tinavi Medical Technologies Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 7.81% |
|
Micro Tech Nanjing Co Ltd
SHG:688029 |
Medical Instruments & Supplies | 1.63% |
|
Tecan Group AG
SW:TECN |
Medical Instruments & Supplies | 20.48% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Tinavi Medical Technologies Co Ltd Asset Resilience Ratio by Year (2015–2025)
Tinavi Medical Technologies Co Ltd asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Tinavi Medical Technologies Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.43% | CN¥41.65 Million ≈ $6.09 Million |
CN¥1.71 Billion ≈ $250.86 Million |
-0.66pp |
| 2023-12-31 | 3.09% | CN¥50.04 Million ≈ $7.32 Million |
CN¥1.62 Billion ≈ $236.98 Million |
+0.23pp |
| 2022-12-31 | 2.86% | CN¥40.20 Million ≈ $5.88 Million |
CN¥1.41 Billion ≈ $205.88 Million |
-6.57pp |
| 2021-12-31 | 9.43% | CN¥120.63 Million ≈ $17.65 Million |
CN¥1.28 Billion ≈ $187.17 Million |
-13.11pp |
| 2020-12-31 | 22.54% | CN¥252.25 Million ≈ $36.91 Million |
CN¥1.12 Billion ≈ $163.79 Million |
-15.69pp |
| 2019-12-31 | 38.23% | CN¥272.81 Million ≈ $39.92 Million |
CN¥713.60 Million ≈ $104.42 Million |
-8.90pp |
| 2015-12-31 | 47.13% | CN¥99.90 Million ≈ $14.62 Million |
CN¥211.96 Million ≈ $31.02 Million |
-- |
About Tinavi Medical Technologies Co Ltd
Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more